Abbott, LGC Team on MDx Biosensor Applications | GenomeWeb

NEW YORK (GenomeWeb News) – British science services firm LGC today said that it has licensed Abbott's Ibis T5000 Biosensor System and will work with Abbott to develop commercial applications for the molecular diagnostics platform.

Under terms of the alliance, the partners will jointly identify and develop commercial diagnostic applications for the T5000, which is currently sold for research uses. LGC received an exclusive license to develop non-clinical applications in the UK and a non-exclusive license to develop clinical and food-testing applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.